Last reviewed · How we verify
ketamine in local intravenous anesthesia — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
ketamine in local intravenous anesthesia (ketamine in local intravenous anesthesia) — Assiut University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ketamine in local intravenous anesthesia TARGET | ketamine in local intravenous anesthesia | Assiut University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ketamine in local intravenous anesthesia CI watch — RSS
- ketamine in local intravenous anesthesia CI watch — Atom
- ketamine in local intravenous anesthesia CI watch — JSON
- ketamine in local intravenous anesthesia alone — RSS
Cite this brief
Drug Landscape (2026). ketamine in local intravenous anesthesia — Competitive Intelligence Brief. https://druglandscape.com/ci/ketamine-in-local-intravenous-anesthesia. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab